Hexagon Capital Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-333
Closed -$26.8K – 701
2025
Q1
$26.8K Buy
333
+11
+3% +$945 0.01% 648
2024
Q4
$25.2K Buy
322
+5
+2% +$425 ﹤0.01% 704
2024
Q3
$29.8K Sell
317
-1
-0.3% -$84 0.01% 570
2024
Q2
$24.7K Buy
318
+39
+14% +$3.18K 0.01% 624
2024
Q1
$25.4K Sell
279
-99
-26% -$8.24K 0.01% 608
2023
Q4
$29.2K Buy
378
+1
+0.3% +$70 0.01% 534
2023
Q3
$25.7K Sell
377
-1
-0.3% -$73 0.01% 496
2023
Q2
$30.7K Sell
378
-3
-0.8% -$239 0.01% 464
2023
Q1
$31.3K Buy
+381
New +$27.2K 0.01% 445

Other funds holding GEHC

Hexagon Capital Partners's GEHC Position: Q2 2025 in Review

Hexagon Capital Partners sold out of GE HealthCare (GEHC) in Q2 2025, closing a stake of 333 shares — an estimated $26.8K sold.

Hexagon Capital Partners first reported a position in GEHC in Q1 2023 and held it in 9 quarters. The position peaked at $31.3K in Q1 2023. 1,316 funds tracked by Wall St. Rank hold GEHC as of Q2 2025.

  • Hexagon Capital Partners reported no remaining GE HealthCare position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 333 GE HealthCare shares in Q2 2025, an estimated $26.8K.
  • Hexagon Capital Partners first reported a position in GE HealthCare in Q1 2023 and held it in 9 quarters.
  • Hexagon Capital Partners's GE HealthCare position peaked at $31.3K in Q1 2023.
  • 1,316 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.